Immunovant, Inc. (IMVT) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts IMVT Hot Sheet
Join SI Premium – FREE
Immunovant, Inc. (NASDAQ: IMVT) reported Q2 EPS of ($0.73), $0.02 worse than the analyst estimate of ($0.71).
For earnings history and earnings-related data on Immunovant, Inc. (IMVT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keefe, Bruyette & Woods Starts Columbia Financial Inc (CLBK) at Outperform
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
- Deutsche Bank Upgrades PennyMac Mortgage Investment Trust (PMT) to Buy
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
